Lunai Bioworks Inc. Cash Flow Statement
LNAI|4 years of annual SEC 10-K data (FY2011-FY2017)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
Lunai Bioworks Inc. used $1M in operating cash flow in FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2014 | FY2011 |
|---|---|---|---|---|
| Net Income | -$1.7M | -$2.4M | -$2.1M | -$38.7K |
| Depreciation & Amortization | $27.4K | $19.0K | $38.3K | - |
| Operating Cash Flow | -$1.5M | -$2.0M | -$2.1M | -$24.9K |